Spudich, S. & Nath, A. Nervous system consequences of COVID-19. Science 375, 267–269 (2022).
Matta, J. et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern. Med. 182, 19–25 (2022).
Xu, E., Xie, Y. & Al-Aly, Z. Long-term neurologic outcomes of COVID-19. Nat. Med. https://doi.org/10.1038/s41591-022-02001-z (2022).
Gao, W., Lv, J., Pang, Y. & Li, L. M. Role of asymptomatic and pre-symptomatic infections in covid-19 pandemic. BMJ 375, n2342 (2021).
Singh, B. et al. Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: an individual patient data meta-analysis. PLoS One 17, e0263595 (2022).
Huang, L. et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir. Med. 10, 863–876 (2022).
de Erausquin, G. A. et al. Chronic neuropsychiatric sequelae of SARS-CoV-2: protocol and methods from the Alzheimer’s Association Global Consortium. Alzheimers Dement. (NY) 8, e12348 (2022).
Douaud, G. et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604, 697–707 (2022).
Beghi, E. et al. Approaches to understanding COVID-19 and its neurological associations. Ann. Neurol. 89, 1059–1067 (2021).
Al-Aly, Z., Bowe, B. & Xie, Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 28, 1461–1467 (2022).